View in EDS HTML Full Text PDF Full Text

Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma.

Saved in:
Bibliographic Details
Title: Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma.
Authors: Romera Martínez, Irene1,2 (AUTHOR) irene.romera@salud.madrid.org, Bueno Cabrera, José Luis1,2 (AUTHOR), Domingo‐Morera, José María3 (AUTHOR), López Aguilar, Juan Carlos4 (AUTHOR), Villegas Da Ros, Carolina5 (AUTHOR), García Erce, José Antonio6,7,8 (AUTHOR), Sáez Serrano, Isabel9 (AUTHOR), Flores Ballester, Elena10 (AUTHOR), Maglio, Laura Analía11 (AUTHOR), Arbona Castaño, Cristina12 (AUTHOR), Sola Lapeña, Carlos13 (AUTHOR), Guerra Domínguez, Luisa14 (AUTHOR), Berberana Fernández, Margarita15 (AUTHOR), Madrigal Sánchez, María Elena16 (AUTHOR), Rubio Batllés, Martín17 (AUTHOR), Pérez‐Olmeda, Mayte18,19 (AUTHOR), Ramos‐Martínez, Antonio20 (AUTHOR), Velasco‐Iglesias, Ana21 (AUTHOR), Avendaño‐Solá, Cristina22,23 (AUTHOR), Duarte, Rafael F.1,2 (AUTHOR)
Source: Vox Sanguinis. Apr2023, Vol. 118 Issue 4, p296-300. 5p. 2 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00429007
DOI:10.1111/vox.13406